Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Optimize the Patient to Optimize the Therapy: Role of Prephase Cyclophosphamide in Aggressive Lymphoma

Nabin Karki, MBBS, Vamsi Kota, MBBS, Katherine Saunders, PharmD, Cara Iacobellis, PharmD, Anand Jillella, MD, Germame Ajebo, MD, Locke J. Bryan, MD

Blood (2019) 134 (Supplement_1): 5294.

https://doi.org/10.1182/blood-2019-129644

Published: 2019

Journal Articles

Trends in Crossover of Patients in Phase III Clinical Trials for Hematologic Malignancies

Justin Yeh, BA, Lakshmi Priyanka Pappoppula, MBBS, Vamsi Kota, Anand Jillella, MD, Achuta Kumar Guddati, MD PhD

Blood (2019) 134 (Supplement_1): 5894.

https://doi.org/10.1182/blood-2019-128667

Published: 2019

Journal Articles

Analysis of Outcomes in Hospitalized Pregnant Patients with Acute Myeloid Leukemia

Achuta Kumar Guddati, MD PhD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2018) 132 (Supplement 1): 3595.

https://doi.org/10.1182/blood-2018-99-118583

Published: 2018

Journal Articles

A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia

Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Stephanie Debragga, Sheldon Bolds, Saleh Alghsoon, Martha L. Arellano, MD, Ravindra Kolhe, MD PhD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 4869.

https://doi.org/10.1182/blood.V130.Suppl_1.4869.4869

Published: 2017

Journal Articles

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Vamsi Kota, MBBS, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Sheldon Bolds, Stephanie Debragga, Kathryn Sarah Simon, PA-C, Martha L. Arellano, MD, Anand Jillella, MD

Blood (2017) 130 (Supplement 1): 5017.

https://doi.org/10.1182/blood.V130.Suppl_1.5017.5017

Published: 2017

Journal Articles

Molecular Characterization By Cancer Immune Profiling in Acute Promyelocytic Leukemia (APL) May Identify Patients at Risk of Early Death

Ravindra Kolhe, MD PhD, Chetan Pundkar, DVM, Ashis Mondal, PhD, Jeremy Pantin, MBBS, Vamsi Kota, MBBS, Amber Clemmons, Anand Jillella, MD

Blood (2017) 130 (Supplement 1): 4976.

https://doi.org/10.1182/blood.V130.Suppl_1.4976.4976

Published: 2017

Journal Articles

Acute Promyelocytic Leukemia (APL) Induction Therapy and Incidence of Renal Insufficiency

Prachi Kharkhanis, Sheldon Bolds, Stephanie Debragga, Catherine R. Caprara, MSN, NP, Kathryn Sarah Simon, PA-C, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5020.

https://doi.org/10.1182/blood.V130.Suppl_1.5020.5020

Published: 2017

Journal Articles

Utility of D-Dimer LEVEL As a Marker for Differentiation Syndrome, Infection, and Death in ACUTE Promyelocytic Leukemia (APL)

Catherine R. Caprara, MSN, NP, Prachi Kharkhanis, Kathryn Sarah Simon, PA-C, Stephanie Debragga, Sheldon Bolds, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5071.

https://doi.org/10.1182/blood.V130.Suppl_1.5071.5071

Published: 2017

Journal Articles

Cerebrovascular Infarcts in the Setting of Disseminated Intravasulcar Coagulation As Presenting Symptom in Acute Promyelocytic Leukemia

Kathryn Sarah Simon, PA-C, Catherine R. Caprara, MSN, NP, Prachi Kharkhanis, Stephanie Debragga, Sheldon Bolds, Martha L. Arellano, MD, Vamsi Kota, MBBS, Anand Jillella, MD

Blood (2017) 130 (Supplement 1): 5034.

https://doi.org/10.1182/blood.V130.Suppl_1.5034.5034

Published: 2017

Journal Articles

Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia

Jee Hyun Kong, Elliott F. Winton, MD, Leonard Heffner, MD, Manila Gaddh, MD, Brittany Hill, PA-C, MMSc, MSc, MPH, Martha Arellano, MD, Fuad El-Rassi, Audrey Kim, Anand Jillella, MD, Vamsi K Kota

Blood (2017) 130 (Supplement 1): 1607.

https://doi.org/10.1182/blood.V130.Suppl_1.1607.1607

Published: 2017

Journal Articles

Availability of ATRA, Blood BANK Support, Treatment Protocols and Hematologists/Oncologists for Management of APL in Two States (MICHIGAN AND LOUSIANA)

Sheldon Bolds, Shruthi M.K Hassan, Catherine R. Caprara, MSN, NP, Stephanie Debragga, Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Arpita Gandhi, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5620.

https://doi.org/10.1182/blood.V130.Suppl_1.5620.5620

Published: 2017

Journal Articles

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Blood (2017) 130 (Supplement 1): 5667.

https://doi.org/10.1182/blood.V130.Suppl_1.5667.5667

Published: 2017

Journal Articles

Comorbid Conditions in Newly Diagnosed Patients with Acute Promyelocytic Leukemia (APL) in "Real World" Patients; Decreased Induction Mortality Despite a High Comorbid Index

Stephanie Debragga, Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Sheldon Bolds, Catherine R. Caprara, MSN, NP, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 3379.

https://doi.org/10.1182/blood.V130.Suppl_1.3379.3379

Published: 2017

Journal Articles

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 1622.

https://doi.org/10.1182/blood.V128.22.1622.1622

Published: 2016

Journal Articles

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 2793.

https://doi.org/10.1182/blood.V128.22.2793.2793

Published: 2016

Journal Articles

Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions

Jee Hyun Kong, MD, Hanna Jean Khoury, MD, Elliott F. Winton, MD, Leonard T. Heffner, MD, Manila Gaddh, MD, Martha Arellano, MD, Fuad El-Rassi, MD, Audrey S Kim, RN, Anand Jillella, MD, Imre Bodó, MDPhD, Vamsi Kota, MD

Blood (2016) 128 (22): 3093.

https://doi.org/10.1182/blood.V128.22.3093.3093

Published: 2016

Journal Articles

Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review

Uma Borate, MD, Amanda Redden Hathaway, MD, Deniz Peker, MD, Bradford E Jackson, PhD, Vamsi K Kota, MD, Bijal D Shah, Ling Zhang, MD, Anand Jillella, MD, Martha Arellano, MD, Leonard T. Heffner, MD, Harry P Erba, MD PhD

Blood (2015) 126 (23): 4869.

https://doi.org/10.1182/blood.V126.23.4869.4869

Published: 2015

Journal Articles

ATRA Availability on Formulary for the Treatment of APL Across Hospitals in the State of Georgia

Sarah Wheeler, PharmD, Harika Puttagunta, MD, Minal Surati, PharmD, Elyse Panjic, PharmD, Arpita Shah, PharmD, Martha Arellano, MD, Anand Jillella, MD, Vamsi K Kota, MD

Blood (2015) 126 (23): 4924.

https://doi.org/10.1182/blood.V126.23.4924.4924

Published: 2015

Journal Articles

Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA

Anand Jillella, MD, Martha Arellano, MD, Asad Bashey, MD PhD, Sarah I. Vidito, DO, Robert K. Stuart, MD, Caleb Leung, Kaitlin Sitchenko, Manila Gaddh, MD, Leonard T Heffner, Jr., MD, Ravindra B. Kolhe, MD PhD, Jacques Galipeau, MD, Amelia Langston, MD, Vamsi K Kota, MD

Blood (2015) 126 (23): 3779.

https://doi.org/10.1182/blood.V126.23.3779.3779

Published: 2015

Journal Articles

Day 30 Platelet Count As a Prognostic Marker of Survival in Acute Myeloid Leukemia

Abhishek Mangaonkar, MBBS, Jamal Mohsin, Joshua Mansour, MD, Ashis Mondal, Ravindra B. Kolhe, MD PhD, Anand Jillella, MD, Vamsi Kota, M.B;B.S, Haarika Puttagunta

Blood (2014) 124 (21): 3684.

https://doi.org/10.1182/blood.V124.21.3684.3684

Published: 2014

NARROW

Optimize the Patient to Optimize the Therapy: Role of Prephase Cyclophosphamide in Aggressive Lymphoma

Trends in Crossover of Patients in Phase III Clinical Trials for Hematologic Malignancies

Analysis of Outcomes in Hospitalized Pregnant Patients with Acute Myeloid Leukemia

A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Molecular Characterization By Cancer Immune Profiling in Acute Promyelocytic Leukemia (APL) May Identify Patients at Risk of Early Death

Acute Promyelocytic Leukemia (APL) Induction Therapy and Incidence of Renal Insufficiency

Utility of D-Dimer LEVEL As a Marker for Differentiation Syndrome, Infection, and Death in ACUTE Promyelocytic Leukemia (APL)

Cerebrovascular Infarcts in the Setting of Disseminated Intravasulcar Coagulation As Presenting Symptom in Acute Promyelocytic Leukemia

Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia

Availability of ATRA, Blood BANK Support, Treatment Protocols and Hematologists/Oncologists for Management of APL in Two States (MICHIGAN AND LOUSIANA)

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Comorbid Conditions in Newly Diagnosed Patients with Acute Promyelocytic Leukemia (APL) in "Real World" Patients; Decreased Induction Mortality Despite a High Comorbid Index

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions

Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review

ATRA Availability on Formulary for the Treatment of APL Across Hospitals in the State of Georgia

Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA

Day 30 Platelet Count As a Prognostic Marker of Survival in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only